Detecting tau in serum of transgenic animal models after tau immunotherapy treatment

Cristina d'Abramo, Christopher M. Acker, Joel B. Schachter, Giuseppe Terracina, Xiaohai Wang, Stefanie K. Forest, Peter Davies

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the attempt to elucidate if the “peripheral sink hypothesis” could be a potential mechanism of action for tau removal in passive immunotherapy experiments, we have examined tau levels in serum of chronically injected JNPL3 and Tg4510 transgenic animals. Measurement of tau in serum of mice treated with tau antibodies is challenging because of the antibody interference in sandwich enzyme-linked immunosorbent assays. To address this issue, we have developed a heat-treatment protocol at acidic pH to remove interfering molecules from serum, with excellent recovery of tau. The present data show that pan-tau and conformational antibodies do increase tau in mouse sera. However, these concentrations in serum do not consistently correlate with reductions of tau pathology in brain, suggesting that large elevations of tau species measured in serum are not predictive of efficacy. Here, we describe a reliable method to detect tau in serum of transgenic animals that have undergone tau immunotherapy. Levels of tau in human serum are less than the sensitivity of current assays, although artifactual signals are common. The method may be useful in similarly treated humans, a situation in which false positive signals are likely.

Original languageEnglish (US)
Pages (from-to)58-65
Number of pages8
JournalNeurobiology of Aging
Volume37
DOIs
StatePublished - Jan 1 2016

Fingerprint

Genetically Modified Animals
Immunotherapy
Animal Models
Serum
Therapeutics
Antibodies
Passive Immunization
Clinical Protocols
Action Potentials
Hot Temperature
Enzyme-Linked Immunosorbent Assay
Pathology
Brain

Keywords

  • Extracellular tau
  • Human antibodies against mouse immunoglobulin
  • Tau ELISA
  • Tau immunotherapy
  • Tau in serum

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. / d'Abramo, Cristina; Acker, Christopher M.; Schachter, Joel B.; Terracina, Giuseppe; Wang, Xiaohai; Forest, Stefanie K.; Davies, Peter.

In: Neurobiology of Aging, Vol. 37, 01.01.2016, p. 58-65.

Research output: Contribution to journalArticle

d'Abramo, Cristina ; Acker, Christopher M. ; Schachter, Joel B. ; Terracina, Giuseppe ; Wang, Xiaohai ; Forest, Stefanie K. ; Davies, Peter. / Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. In: Neurobiology of Aging. 2016 ; Vol. 37. pp. 58-65.
@article{abfa92d8ebfd4677bf72112071fa7d38,
title = "Detecting tau in serum of transgenic animal models after tau immunotherapy treatment",
abstract = "In the attempt to elucidate if the “peripheral sink hypothesis” could be a potential mechanism of action for tau removal in passive immunotherapy experiments, we have examined tau levels in serum of chronically injected JNPL3 and Tg4510 transgenic animals. Measurement of tau in serum of mice treated with tau antibodies is challenging because of the antibody interference in sandwich enzyme-linked immunosorbent assays. To address this issue, we have developed a heat-treatment protocol at acidic pH to remove interfering molecules from serum, with excellent recovery of tau. The present data show that pan-tau and conformational antibodies do increase tau in mouse sera. However, these concentrations in serum do not consistently correlate with reductions of tau pathology in brain, suggesting that large elevations of tau species measured in serum are not predictive of efficacy. Here, we describe a reliable method to detect tau in serum of transgenic animals that have undergone tau immunotherapy. Levels of tau in human serum are less than the sensitivity of current assays, although artifactual signals are common. The method may be useful in similarly treated humans, a situation in which false positive signals are likely.",
keywords = "Extracellular tau, Human antibodies against mouse immunoglobulin, Tau ELISA, Tau immunotherapy, Tau in serum",
author = "Cristina d'Abramo and Acker, {Christopher M.} and Schachter, {Joel B.} and Giuseppe Terracina and Xiaohai Wang and Forest, {Stefanie K.} and Peter Davies",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2015.09.017",
language = "English (US)",
volume = "37",
pages = "58--65",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Detecting tau in serum of transgenic animal models after tau immunotherapy treatment

AU - d'Abramo, Cristina

AU - Acker, Christopher M.

AU - Schachter, Joel B.

AU - Terracina, Giuseppe

AU - Wang, Xiaohai

AU - Forest, Stefanie K.

AU - Davies, Peter

PY - 2016/1/1

Y1 - 2016/1/1

N2 - In the attempt to elucidate if the “peripheral sink hypothesis” could be a potential mechanism of action for tau removal in passive immunotherapy experiments, we have examined tau levels in serum of chronically injected JNPL3 and Tg4510 transgenic animals. Measurement of tau in serum of mice treated with tau antibodies is challenging because of the antibody interference in sandwich enzyme-linked immunosorbent assays. To address this issue, we have developed a heat-treatment protocol at acidic pH to remove interfering molecules from serum, with excellent recovery of tau. The present data show that pan-tau and conformational antibodies do increase tau in mouse sera. However, these concentrations in serum do not consistently correlate with reductions of tau pathology in brain, suggesting that large elevations of tau species measured in serum are not predictive of efficacy. Here, we describe a reliable method to detect tau in serum of transgenic animals that have undergone tau immunotherapy. Levels of tau in human serum are less than the sensitivity of current assays, although artifactual signals are common. The method may be useful in similarly treated humans, a situation in which false positive signals are likely.

AB - In the attempt to elucidate if the “peripheral sink hypothesis” could be a potential mechanism of action for tau removal in passive immunotherapy experiments, we have examined tau levels in serum of chronically injected JNPL3 and Tg4510 transgenic animals. Measurement of tau in serum of mice treated with tau antibodies is challenging because of the antibody interference in sandwich enzyme-linked immunosorbent assays. To address this issue, we have developed a heat-treatment protocol at acidic pH to remove interfering molecules from serum, with excellent recovery of tau. The present data show that pan-tau and conformational antibodies do increase tau in mouse sera. However, these concentrations in serum do not consistently correlate with reductions of tau pathology in brain, suggesting that large elevations of tau species measured in serum are not predictive of efficacy. Here, we describe a reliable method to detect tau in serum of transgenic animals that have undergone tau immunotherapy. Levels of tau in human serum are less than the sensitivity of current assays, although artifactual signals are common. The method may be useful in similarly treated humans, a situation in which false positive signals are likely.

KW - Extracellular tau

KW - Human antibodies against mouse immunoglobulin

KW - Tau ELISA

KW - Tau immunotherapy

KW - Tau in serum

UR - http://www.scopus.com/inward/record.url?scp=84951038196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951038196&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2015.09.017

DO - 10.1016/j.neurobiolaging.2015.09.017

M3 - Article

C2 - 26508157

AN - SCOPUS:84951038196

VL - 37

SP - 58

EP - 65

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -